SightfileU.S. market data from official filings
Companies › ZLAB
ZAI LAB LTD (ZLAB)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001704292 · EDGAR filings · Updated 2026-07-06
ZAI LAB LTD (ZLAB) has reported institutional ownership of 2.5%, with 98 institutional managers holding positions valued at $530.9M per the latest 13F reporting period.
Institutional ownership
2.5%
Institutional managers
98
Reported 13F value
$530.9M
Insider activity
111 trans.
−$22.7M net selling
Latest updates
- 2026-07-06 — Insider transaction reported (Form 4)
- 2026-07-06 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-06-30 — Notice of proposed sale filed (Form 144)
- 2026-06-29 — Insider transaction reported (Form 4)
- 2026-06-29 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ZAI LAB LTD has 98 institutional holders and institutional ownership of 2.5%.
Insider activity
Insiders reported 111 transactions (2 buys, 53 sells) across 13 reporting insiders, with a net reported value of −$22.7M.
Related companies
EMBECTA CORP (EMBC) · OCULIS HOLDING AG (OCS) · KAMADA LTD (KMDA) · MYRIAD GENETICS INC (MYGN) · PRECIGEN (PGEN) · BRIDGEBIO ONCOLOGY THERAPEUTIC (BBOT)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-06.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-06.